Lonza | LONN - Beneficio Bruto En Ventas

Precio De Mercado
469.00
Cambio Diario
-4.30 -0.91%
Mensual
-9.91%
Anual
-17.49%
Q1 Expectativa
468.93




Beneficio Bruto En Ventas Cambio Fecha
Akzo Nobel EUR 1.04B 10M 2025-06
Alcon AG USD 1.52B 58M 2025-12
Almirall EUR 429.87M 180.02M 2025-12
AstraZeneca USD 12.39B 5M 2025-12
BASF EUR 3.11B 55M 2025-12
Bayer EUR 5.35B 1.02B 2025-09
Beiersdorf EUR 1.54B 1.16B 2025-06
Covestro EUR 488M 64M 2025-09
Demant DKK 8.82B 277M 2025-12
Fresenius EUR 1.51B 214M 2025-12
Fresenius Medical Care EUR 1.39B 147M 2025-12
Geberit CHF 524.3M 125.1M 2025-12
Genmab DKK 977M 13M 2025-12
Givaudan CHF 1.55B 140M 2025-12
GlaxoSmithKline GBP 6.18B 106M 2025-12
GN Store Nord DKK 2.5B 344M 2025-12
Hikma Pharmaceutical USD 362.5M 329.5M 2025-06
Johnson Matthey GBP 480M 33M 2024-06
Merck EUR 2.96B 252M 2025-12
Novartis USD 10.25B 570M 2025-12
Philips EUR 2.29B 377M 2025-12
Roche Holding CHF 22.09B 10.04B 2025-12
Sanofi EUR 8.45B 1.31B 2025-12
Sika AG CHF 3.02B 104.6M 2025-12
Smith & Nephew USD 2.09B 117M 2025-12
Solvay EUR 265M 13M 2025-09
UCB EUR 3.19B 621M 2025-12